ILMN

Illumina, Inc.

Halal Rating :
Comfortable
Last Price $135.90 Last updated:
Market Cap $20.93b
7D Change -5.54%
1 Year Change -3.09%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Measuring And Control Equipment
  • Lab Analytical Instruments
Exchange NASDAQ
Next Earnings Date Nov. 7, 2024

Illumina, Inc. is a global leader in DNA sequencing and array-based technologies. The company develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Their products enable customers to read and understand genetic variations, which is essential for medical diagnosis, drug development, and scientific research.

The company's core business involves selling instruments, consumables, and services for genetic analysis, particularly in areas like reproductive health, oncology research, and genetic disease research. Their technology platforms include sequencing by synthesis (SBS), microarray scanning, and various data analysis tools.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 29, 2024 $1.08b $375.0m - $36.0m 0.00% 9.60%
June 30, 2024 $1.11b $2.77b - $20.0m 0.00% 0.72%
March 31, 2024 $1.08b $1.21b - $18.0m 0.00% 1.49%

Company Impact

Help us evaluate Illumina, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates